INTRODUCTION
The outer membrane of Gram-negative bacteria contains the unique molecule lipopolysaccha- ride (LPS), which consists of three covalently linked regions. Integrated into the outer membrane is the lipid A moiety, an acylated glucosamine disaccharide, extending outwards from which is a short oligosaccharide, the core. In virtually all Gram-negative bacteria the core oligosaccharide is linked to lipid A by a 3-deoxy-D-manno-2-octulosonate (KDO) dimer [1] [2] [3] . In so called 'smooth' strains a long carbohydrate polymer, the O-side chain, extends from the core region [4] . KDO is recognized as a promising target for the development of novel antibacterials acting against Gram-negatives as the inability to produce KDO is a lethal event [5] . Additionally, since KDO is not found in mammalian cells, agents directed against its biosynthesis should possess high selective toxicity.
The LPS component of the outer membrane allows Gram-negative bacteria to persist in vivo and thereby directly contributes to their virulence [6, 7] . Inhibitors of LPS should therefore have an advantage over other antibacterials in that, even at sub-inhibitory concentrations, the ability of the bacteria to successfully evade host defence mechanisms will be reduced. The diazoborane Sa84474 [8] appears to inhibit LPS-biosynthesis by block-294 ing the incorporation of lipids into lipid A. Although this compound has proved too toxic for use in chemotherapy it has been shown to reduce the virulence properties of E. coli [9] . This study was undertaken to determine if the same held true for KDO-inhibitors.
MATERIALS AND METHODS

Bacterial strains
Type strains were obtained from the American Type Culture Collection, Rockville, MD. S. typhimurium AG701i50 (kdsA ts) was kindly supplied by M.J. Osborn. E. coli C10 (O7:KI) and D120 (K1) were originally isolated from neonatal meningitis patients [10] .
Antibacterials
Peptide derivatives of NH2dKDO were synthesized [3] in the laboratories of Astra AB, Sodertalje, Sweden. Sa84474 was supplied by the Sandoz Forschungsinstitut, Vienna. Antibiotics were obtained from Sigma.
Minimum inhibitory concentration (MIC)
Two-fold serial dilutions of the antibacterials were made in the peptide-free medium of Goldman and Leive [11] or using MacConkey Broth (Oxoid) in the wells of a microtitre plate giving a final volume of 100 /xl. Bacteria (103) from an overnight culture were inoculated into each well and the plate incubated at 37°C overnight. The MIC was determined as the lowest drug concentration at which no turbidity could be detected.
Serum bactericidal assay
The survival of bacterial strains in pooled normal human serum was determined as described previously [6] . Bacteria were incubated with the drug in minimal medium for 1 h before exposure to the serum.
Phagocytosis assay
Bacteria grown at 37°C in nutrient broth until mid-exponential phase, were harvested by centrifugation, washed twice in phosphate-buffered saline pH 7.3 (PBS), incubated with or without drug for 1 h at 37°C, and recentrifuged. The bacteria were opsonized by resuspending the pellet in 20% human serum in PBS, incubating at 37°C for 20 min, washing twice more in PBS and finally resuspending in PBS.
Human polymorphonuclear leukocytes (PMNLs) were prepared from fresh heparinised human blood by sedimentation through Dextran (6% w/v in 0.9% saline)-Isopaque 440 (45% in distilled water) for 45 min at 37°C. The leukocyte rich fraction was diluted 1 : 1 in PBS and then the PMNLs separated by a gentle centrifugation (400 × g, 25 min) through Ficoll (0.9% w/v)-Isopaque (45%). The pellet was suspended in lysing solution (0.15 M NH4CI, 0.01 M NaHCO 3, and 0.1 mM EDTA at 4°C, washed in PBS and resuspended in Minimal Eagles Medium (Flow Laboratories) supplemented with 18% AB serum at a PMNL concentration of 107/ml. 100/xl of opsonized bacteria, 100 p~l of PMNLs and 50/xl of 10 -4 M luminol (Sigma) in DMSO were mixed in a cuvette at 37°C and chemiluminescence monitored using a LKB 1250 luminometer. 25-/xl aliquots were withdrawn from the cuvette at the beginning and end of the experiment, the PMNLs lysed by serial dilution in ice-cold distilled water and the number of viable bacteria determined by plating on nutrient agar.
Virulence determination (LDso)
The virulence of E. coli C10 after exposure to the antibacterial was determined in mice; groups of five Charles River mice received the respective bacterial challenge suspended in 5% hog gastric mucin (Sigma). The 50% lethal dose was calculated by the method of Spearman and Karber [12] .
7. Bacterial clearance
E. coli D120 was grown overnight in Brain Heart Infusion, centrifuged (4000 xg, 20 min) and resuspended in normal saline at 10S/ml. LPS inhibitors were added to the suspension and after 1 h 0.1 ml of the suspensions injected i.v. into mice (five mice per sample), which were bled at set time-intervals and the number of viable bacteria determined by serial dilution in saline followed by plating upon nutrient agar.
RESULTS AND DISCUSSION
NH2dKDO is a potent, specific inhibitor of CMP-KDO synthetase, but because it cannot penetrate to the bacterial cytoplasm it has little antibacterial activity itself. Linking a short peptide to NHzdKDO produces compounds that are active against most Gram-negative bacteria, but not Gram-positives [1] [2] [3] . Because these antimicrobials utilize peptide permeases to cross the bacterial cytoplasmic membrane to reach their target [1] , their antimicrobial effect is greatest in peptide-free free medium (Table 1) . Repeating the MIC determinations in peptide-rich medium, e.g. iso-sensitest or nutrient broth gives values at least one order of magnitude higher (data not shown). However, if MICs are performed in MacConkey broth, which contains 0.4% bile salts and crystal violet, the MIC is markedly lower (Table  1) . This was not true for ampicillin. One vital function of the Gram-negative outer membrane is to provide a protective barrier against hostile environments: presumably LPS-inhibitors disturb the ordered biosynthesis of this membrane, rendering it more permeable to chaotrophic agents such as those present in bile salts and to crystal violet. Similarly, bacteria pre-treated with dipeptide-substituted NHzdKDOs became sensitive to hydrophobic antibiotics such as nafcillin, spiramycin, novobiocin or cerulenin (data not shown). Similar results were seen with the diazoborane Sa84474. Presumably these drugs, by decreasing the amount of LPS, increase the lipophilicity of the outer membrane and thereby promote the action of detergents and facilitate the penetration of hydrophobic antibiotics. An intact outer membrane is also a vital part of the bacterium's resistance to the complementmediated bactericidal action of serum [7] and its ability to resist the attentions of professional phagocytes [13] . E. coli D120 is highly resistant to serum, being able to grow and divide normally in neat human serum. Bacteria treated with Alaala-NHdKDO (or any other of the dipeptide-lin- Table 1 Antibacterial activity (MICs) of three dipeptide substituted NHdKDO's in peptide-free medium [11] ked inhibitors) or Sa84474 sensitized E. coli D120 to human serum (Fig. 1 ). An increase in chemiluminescence that accompanies the respiratory burst upon particle ingestion by isolated PMNLs, can be taken as an indication of increased bacterial vulnerability to ingestion by polymorphs. Pre-treatment of E. coli C10 with sub-inhibitory concentrations of Alaala-NHdkDO or Sa84474 dramatically increased the chemiluminescence signal (Fig. 2) , accompanied by a fall in the number of viable bacteria (from 8.8 x 10S/ml to 4.4 × 106/ml and from 7.1 x 108/ml to 6.3 × 106/ml respectively). In duplicate samples without PMNLs the viable counts varied by only _+10%. The untreated control elicited a minimal chemiluminescence response; the number of bacteria rising from 1.1 x 109/ml to 2.9 × 109/ml.
Dipeptide derivatives of NH2dKDO possess insufficient metabolic stability to maintain therapeutic blood-levels in experimental animals. It appears that the N-terminal amino acid is lost in the animal producing a mono-aminoacylated inhibitor, which, because it is not transported into the bacterium [1] , has no antibacterial activity. Hence any in vivo experiments must be performed using bacteria treated in vitro before injection. Under these limited conditions low concentrations of LPS inhibitors also increased the rate at which E. coli D120 was cleared from the bloodstream (Fig. 3) . LPS is certainly not the only, or even the dominant, determinant of virulence on the surface of E. coli, indeed the possession of capsular layers (e.g. K1 or K5) [6, 7, 14] are probably more important. However, inhibiting LPS biosynthesis does appear to reduce the ability of E. coli cells to survive the bactericidal activity of serum, to avoid the attentions of phagocytes and causes the bacterial cells to be cleared more readily from the Table 2 50% lethal doses for E. coli C10 pretreated with sub-inhibitory concentrations of LPS inhibitors Treatment None Ala-ala-NHdKDO (0.5 raM) Ala-ala-NHdKDO (1 mM) Pro-met-NHdkDO (1 mM) Sa84474 (5 ~g/ml) LD50 in mouse 7.5 x 102 2.1x104 1.6 x 105 8.1 × 10 4 3.3x10 4
Mid-exponential cells (5 x 10 s) treated with drug in minimal medium for 1 h, centrifuged free of drug and resuspended in 5% hog gastric mucin before challenge.
body (Fig. 3 , Table 2 ). Whether these phenomena are the direct result of a reduced LPS content of caused indirectly by consequent changes in other envelope polymers or virulence factors remains to be established.
